Cargando…

Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial

INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon-Sanz, Miguel, Linares, Francisca, Gonzalo, Montserrat, Tapia, María José, Maiz-Jimenez, María, Ruiz Aguado, Marta, Lizán, Luis, Olveira, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186345/
https://www.ncbi.nlm.nih.gov/pubmed/37200944
http://dx.doi.org/10.3389/fnut.2023.1182445
_version_ 1785042539889295360
author Leon-Sanz, Miguel
Linares, Francisca
Gonzalo, Montserrat
Tapia, María José
Maiz-Jimenez, María
Ruiz Aguado, Marta
Lizán, Luis
Olveira, Gabriel
author_facet Leon-Sanz, Miguel
Linares, Francisca
Gonzalo, Montserrat
Tapia, María José
Maiz-Jimenez, María
Ruiz Aguado, Marta
Lizán, Luis
Olveira, Gabriel
author_sort Leon-Sanz, Miguel
collection PubMed
description INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, open-label crossover trial was conducted in outpatients with DRM to compare compliance with a high energy-dense ONS (edONS, 2.4 kcal/mL) and a reference ONS (heONS, 2.0 kcal/mL; NCT05609006). Patients were randomly assigned to two 8-week treatment sequences of four-weeks periods: edONS + heONS (sequence A) or heONS + edONS (sequence B). Patients daily reported the amount of product left over gastrointestinal tolerance and satisfaction with ONS. A non-inferiority analysis was performed to compare the compliance rate (percentage of consumed energy over the prescribed) for each period and sequence. RESULTS: Fifty-three patients were assigned to sequence A and 50 to sequence B (55.7 ± 13.9 years, 37.0% female, 67.1% oncology patients). In sequence A, the compliance rates were 88.6% ± 14.3% vs. 84.1 ± 21.8% (p = 0.183), while in sequence B, they were 78.9% ± 23.8% vs. 84.4% ± 21.4% (p < 0.01). In both sequences, the lower range of the confidence interval for compliance with edONS was greater than the non-inferiority threshold (for sequence A Δ(Comp)(A) was 4.5% [95% CI, −2.0% to 10.0%], and for sequence, B Δ(Comp)(B) was 5.6% [95% CI, −3.0% to 14.0%]). The total discarded cost for each ONS was higher for heONS than edONS, being the difference statistically significant in sequence B. BMI increased slightly and not significantly in both sequences, and the percentage of patients with severe malnutrition was reduced. The frequency of gastrointestinal symptoms was low for both sequences, and satisfaction with ONS was slightly higher for edONS. CONCLUSION: Our findings highlight that edONS was non-inferior to heONS in terms of consumed energy over the prescribed, with a lower amount of edONS discarded, which suggests a higher efficiency of edONS.
format Online
Article
Text
id pubmed-10186345
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101863452023-05-17 Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial Leon-Sanz, Miguel Linares, Francisca Gonzalo, Montserrat Tapia, María José Maiz-Jimenez, María Ruiz Aguado, Marta Lizán, Luis Olveira, Gabriel Front Nutr Nutrition INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, open-label crossover trial was conducted in outpatients with DRM to compare compliance with a high energy-dense ONS (edONS, 2.4 kcal/mL) and a reference ONS (heONS, 2.0 kcal/mL; NCT05609006). Patients were randomly assigned to two 8-week treatment sequences of four-weeks periods: edONS + heONS (sequence A) or heONS + edONS (sequence B). Patients daily reported the amount of product left over gastrointestinal tolerance and satisfaction with ONS. A non-inferiority analysis was performed to compare the compliance rate (percentage of consumed energy over the prescribed) for each period and sequence. RESULTS: Fifty-three patients were assigned to sequence A and 50 to sequence B (55.7 ± 13.9 years, 37.0% female, 67.1% oncology patients). In sequence A, the compliance rates were 88.6% ± 14.3% vs. 84.1 ± 21.8% (p = 0.183), while in sequence B, they were 78.9% ± 23.8% vs. 84.4% ± 21.4% (p < 0.01). In both sequences, the lower range of the confidence interval for compliance with edONS was greater than the non-inferiority threshold (for sequence A Δ(Comp)(A) was 4.5% [95% CI, −2.0% to 10.0%], and for sequence, B Δ(Comp)(B) was 5.6% [95% CI, −3.0% to 14.0%]). The total discarded cost for each ONS was higher for heONS than edONS, being the difference statistically significant in sequence B. BMI increased slightly and not significantly in both sequences, and the percentage of patients with severe malnutrition was reduced. The frequency of gastrointestinal symptoms was low for both sequences, and satisfaction with ONS was slightly higher for edONS. CONCLUSION: Our findings highlight that edONS was non-inferior to heONS in terms of consumed energy over the prescribed, with a lower amount of edONS discarded, which suggests a higher efficiency of edONS. Frontiers Media S.A. 2023-05-02 /pmc/articles/PMC10186345/ /pubmed/37200944 http://dx.doi.org/10.3389/fnut.2023.1182445 Text en Copyright © 2023 Leon-Sanz, Linares, Gonzalo, Tapia, Maiz-Jimenez, Ruiz Aguado, Lizán and Olveira. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Leon-Sanz, Miguel
Linares, Francisca
Gonzalo, Montserrat
Tapia, María José
Maiz-Jimenez, María
Ruiz Aguado, Marta
Lizán, Luis
Olveira, Gabriel
Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title_full Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title_fullStr Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title_full_unstemmed Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title_short Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
title_sort compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186345/
https://www.ncbi.nlm.nih.gov/pubmed/37200944
http://dx.doi.org/10.3389/fnut.2023.1182445
work_keys_str_mv AT leonsanzmiguel compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT linaresfrancisca compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT gonzalomontserrat compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT tapiamariajose compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT maizjimenezmaria compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT ruizaguadomarta compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT lizanluis compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial
AT olveiragabriel compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial